StageAcquired | Acquired
Segetis is a technology-enabled green chemistry company producing versatile chemical building blocks. This new platform harnesses the power and reliability of renewable agricultural and forestry resources. Powered by its Javelin Technology, this portfolio of biobased products are backed by a strong intellectual asset portfolio built on filed composition of matter patents. Segetis has a focus on Performance First and is transforming the chemical industry by offering material properties, cost effective economics and an improved health and environmental footprint. On February 16th, 2016, Segetis was acquired by GFBiochemicals, terms of the agreement were not disclosed.
Missing: Segetis's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Segetis's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Segetis
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Segetis is included in 2 Expert Collections, including Advanced Materials.
Startups developing new or improved materials (chemicals, alloys, etc.) that provide physical or functional advantages to basic materials.
Agriculture Technology (Agtech)
Companies that are using technology to make farms more efficient.
Segetis has filed 37 patents.
Plasticizers, Food additives, Chemical processes, Chemical reactions, Amines
Plasticizers, Food additives, Chemical processes, Chemical reactions, Amines
Latest Segetis News
Jan 4, 2023
Levulinic acid market is expected to grow 4X during 2022 – 2032. U.S. accounts for the largest market for Levulinic Acid accounting for over 30% share in the global market Levulinic acid revenue through agriculture application is projected to gross the highest revenue, with a projected CAGR of 18.3% during the forecast period. Applications of Levulinic Acid in Agriculture and Pharmaceuticals to contribute the most to revenue Agriculture is the top application of Levulinic Acid with a historical CAGR of 12.6%. Delta Amino Levulinic Acid is a widely used herbicide derived from Levulinic acid. Pharmaceuticals are an emerging component of demand, with a historical CAGR of 11.5% and a forecasted CAGR of 16.3%, accounting for US$ 39.6 Mn of forecasted revenue in 2032. Pharmaceutical applications are varied, including supplements, medicine, drug delivery systems, and in drug synthesis. Get Customization on this Report for Specific Research Solutions: The United States to continue being the Nucleus of Global Levulinic Acid Demand The US is the nucleus of global demand, with a forecasted market size of US$ 39 Mn at a CAGR of 15.9% and 2021 market size of US$ 8.2 Mn with a historical CAGR of 11.2%. Levulinic Acid is FDA-approved. In 2022, the DOE or the United States Department of Energy identified Levulinic acid as an important platform chemical for green industrial chemical process development. In 2019, The Maine Technology Institute announced that had awarded funding to a bio-based Levulinic acid project by Biofine Developments Northeast. Competition Insights Levulinic Acid developers are focused on further research to harness the edge their products are gaining due to their environmental benefits. The key companies operating include Anhui Herman Impex Co Ltd, AkzoNobel, Avantium, International Inc., CSPC Pharmaceutical Group, DuPont, G.F. Biochemicals Ltd, Great Chemicals Co. Ltd., Hebei Shijiazhuang Hefei TNJ Chemical Industry Co., Ltd., Jotun A/S, KCC Corporation, Langfang Triple Well Chemicals Co. Ltd, Simagchem Corporation, Sherwin-Williams, Segetis and The Valspar Corporation, amongst others. Some of the recent developments in Levulinic Acid are as follows: In May 2022, GF Biochemicals announced that they had raised US$ 16 Mn in their series A funding, with plans to use the money generated for R&D and the development of a new facility. In June 2021, Origin Materials, a carbon-negative materials company that has, among other products, Levulinic acid as a product, announced the listing of their shares on NASDAQ through a SPAC merger, which puts the valuation of Origin at US$ 1.8 Bn. In February 2020, GF Biochemicals and Towell Engineering announced a partnership through the forming of a joint venture under the name Nxtlevvel. Nxxtlevvel plans to open a plant in Europe or India, aiming to produce and sell Levulinic acid derivatives. In March 2017, Bio-On and Sadam Group announced the launch of a new project, which aims to produce Levulinic acid from the sugar industry by-products. In January 2022, Summit Cosmetics Corporation, or SCC and NXTLEVVEL, announced a Global Distribution Agreement, which gives SCC sales rights for 5 years. In October 2021, Brenntag and NXTLEVVEL announced a distribution contract. Under this contract, the lineup includes levulinates and levulinate ketals Key Companies AkzoNobel Jotun A/S Simagchem Corporation By Application: More Insights Available Fact.MR, in its new offering, presents an unbiased analysis of the Global Levulinic Acid Market, presenting historical market data (2017-2021) and forecast statistics for the period of 2022-2032. The study reveals extensive growth in Global Levulinic Market by Application (Agriculture, Pharmaceutical, Food Additives, and Other Applications), across five regions (North America, Asia Pacific, Europe, Middle East & Africa and Latin America). Check out more related studies published by Fact.MR Research: Fumaric Acid Market - The fumaric acid market valuation is anticipated to grow at a CAGR of 6.7% over the forecast period i.e., 2022 to 2032. Global fumaric acid sales valuation is set to reach US$ 645 Mn by 2032 end, which amounts to approx. 1.2% of the overall food additive sales as per the latest study by Fact.MR - a market research and competitive intelligence provider. Bio-Based Acetic Acid Market - Recently released bio-based acetic acid market analysis by Fact.MR, a market research and competitive intelligence provider, showcases that the market reached US$ 44.1 Mn in 2020, and is expected to be valued over US$ 45.6 Mn by 2021-end. However, owing to gradual recovery and rising demand followed by increasing production, overall revenue is projected to grow 1.6X from 2021 to 2031. Thioacetic Acid Market - The growth of the food processing and pharmaceutical industries involving the augmentation of production will help increase the market for thioacetic acid. The development of new drugs and medicines with thioacetic acid base compounds as intermediates will also help the thioacetic acid market to grow. The increase in the demand for petrochemicals will lead to the growth of the polymer and rubber market, and thus, will increase the thioacetic acid market. Acid Anhydrides Market - The rapid industrialization and increasing construction activities are escalating the growth of the acid anhydrides market. The significant growth in end-use industries in emerging economies such as China and India is anticipated to propel the consumption of acid anhydrides. Latin America and Middle East & Africa showcase significant growth due to the rise in construction activities in respective regions. Isatoic Acid Anhydride Market - The global Isatoic Acid Anhydride market is segmented into seven regions including North America, Latin America, Europe, East Asia, South Asia, Oceania and MEA. Among the above-mentioned regions, Asia is estimated to account for more than 30% of global Isatoic Acid Anhydride consumption with key producers having their Isatoic Acid Anhydride manufacturing facilities in the regions. About Fact.MR We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client’s satisfaction. Contact:
Segetis Frequently Asked Questions (FAQ)
When was Segetis founded?
Segetis was founded in 2006.
Where is Segetis's headquarters?
Segetis's headquarters is located at 680 Mendelssohn Ave N, Minneapolis.
What is Segetis's latest funding round?
Segetis's latest funding round is Acquired.
How much did Segetis raise?
Segetis raised a total of $74.67M.
Who are the investors of Segetis?
Investors of Segetis include GFBiochemicals, Khosla Ventures, Malaysian Life Sciences Capital Fund, DSM Venturing, SABIC Ventures and 3 more.
Who are Segetis's competitors?
Competitors of Segetis include Novomer.
Compare Segetis to Competitors
Yield10 Bioscience, formerly Metabolix, develops disruptive technologies for producing step-change improvements in crop yield to enhance global food security. Yield10 is leveraging an extensive track record of innovation based around optimizing the flow of carbon intermediates in living systems. By working on new approaches to improve fundamental elements of plant photosynthetic efficiency and optimizing carbon metabolism to direct more carbon to seed production, Yield10 is advancing several yield traits it has developed in crops such as Camelina, canola, soybean and corn.
Novomer is a materials company commercializing a family of low-cost, high-performance, sustainable polymers, and other chemicals. Novomer's catalyst technology allows carbon dioxide and other renewable feedstocks to be cost-effectively transformed into chemical products for a wide variety of industrial markets. In 2021, Novomer was acquired by DaniMer Scientific at a valuation of $152M.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.